Singapore, June 4 -- The Health Sciences Authority received information related to the study titled 'Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascendi... और पढ़ें
Singapore, June 4 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant V... और पढ़ें
Singapore, June 4 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant V... और पढ़ें
Singapore, June 4 -- The Health Sciences Authority received information related to the study titled 'A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway ... और पढ़ें
Singapore, June 4 -- The Health Sciences Authority received information related to the study titled 'CA088-1007: A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety... और पढ़ें
Singapore, June 4 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of Lut... और पढ़ें
Singapore, June 4 -- The Health Sciences Authority received information related to the study titled 'CO45042: A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasib ... और पढ़ें
Singapore, June 4 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durv... और पढ़ें
U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07624695) titled 'Multidisciplinary Health Literacy Intervention in Preschool Children' on May 28. Brief Summ... और पढ़ें
U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07623798) titled 'A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003' on May 21.... और पढ़ें